This inventor holds 13 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Chirogate International Inc., Irogate International Inc., Other. Active years: 2009-2020.
Location History:
- Taipei, TW (2009 - 2013)
- Yangmei, TW (2013 - 2020)
Company Filing History:
11 out of 30 
1 out of 1 
1 out of 834,411 Years Active: 2009-2020
Title: Yu-Chih Yeh: Innovator in Prostaglandin Preparation
Introduction
Yu-Chih Yeh, a talented inventor based in Yangmei, Taiwan, has made significant contributions to the field of prostaglandin preparation. With a remarkable portfolio encompassing 13 patents, he is recognized as a key figure in innovation related to pharmaceutical processes.
Latest Patents
Among his noteworthy inventions, Yu-Chih Yeh has developed novel processes and intermediates for the preparations of isomer-free prostaglandins. His latest patents focus on processes for the preparation of a compound of Formula I-2, which is substantially free of the 5,6-trans isomer. These patents not only detail the processes for creating these innovative compounds but also provide novel intermediates for the preparations of isomer-free prostaglandins and their derivatives.
Career Highlights
Throughout his career, Yu-Chih Yeh has worked with prominent companies in the industry, notably Chirogate International Inc. and Irogate International Inc. His work in these organizations has allowed him to push the boundaries of existing technology and methodologies in the pharmaceutical field.
Collaborations
Yu-Chih Yeh has collaborated with several professionals in his field, including Shih-Yi Wei and Min-Kuan Hsu. These collaborations have facilitated the exchange of ideas and enhancements in research, contributing to the rich vein of innovation stemming from their joint efforts.
Conclusion
In summary, Yu-Chih Yeh stands out as a significant innovator in the domain of prostaglandin preparation. His commitment to advancing the field is demonstrated through his numerous patents and collaborations. As the pharmaceutical industry continues to evolve, his contributions may lead to new breakthroughs that benefit both science and healthcare.